We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
U.k. Spac Plc | LSE:SPC | London | Ordinary Share | GB00B3CQW227 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.205 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/6/2022 20:48 | hellenic's advisory board members prof mike barnes and hannah deacon, both to be speakers at 28/29 jun [fingers x'd listed by then!] -- ps. hopefully nxt announcement is to say prospectus being distributed and give gm date/venue. warrants expire tomorrow, but those holders have been given their pitch via webinar, so maybe that date is now of less significance | wrtmf | |
08/6/2022 10:00 | Hellenic Dynamics @HellenicDynami1·16m A study has found that higher levels of THC within #medicalcannabis is more effective at treating pain. With a chronic pain pandemic applying pressure on health care systems, this is a welcome finding for those seeking more clarity on treatment options. | wrtmf | |
08/6/2022 08:47 | passing the time... Hellenic Dynamics @HellenicDynami1 ·2 Jun The Oklahoma governor has signed the final round of #medicalcannabis legislation, in order to ensure that the quality of product and safety remain high. Regulation is essential for all medical treatment, as this ensures patients safety. Hellenic Dynamics @HellenicDynami1·3 Jun In a retrospective Canadian study of 7000 adults, #cannabis use improved depression and anxiety in people diagnosed with these conditions. #Medicalcannabis can be an effective treatment for mental health and we believe research in this field is vital. Hellenic Dynamics @HellenicDynami1·6 Jun A new study aims to find out the most effective ratio of cannabinoids in the treatment of anxiety. With those suffering from anxiety increasing significantly over the past few years, the study is highly welcomed by many. Hellenic Dynamics @HellenicDynami1·6 Jun This is positive news! 👏 It is vital that more countries and governments explore routes towards adopting #medicalcannabis to ensure education and access are open to as many people as possible. [Japan Considers Very Limited Medical Cannabis Reform] Hellenic Dynamics @HellenicDynami1·22h With over 1.5m women diagnosed with endometriosis, a chronic pain condition, #medicalcannabis has proven to be an effective treatment. Yet with NHS doctors prioritising other options, access to #medicalcannabis is still limited. We are focused on changing this! Hellenic Dynamics @HellenicDynami1·21h Researchers are analysing #medicalcannabis as a treatment option for pain and cancer. "Traditionally, cancer-related pain is mainly treated by opioids, but most oncologists perceive opioid treatment as hazardous, so alternative therapies are required.” -- spc meeting with eligibility committee this week to sign off prospectus? | wrtmf | |
06/6/2022 12:33 | So what are they supposed to be scamming? | muchodinero | |
05/6/2022 15:28 | Scammers are out in force today!! Don't get scammed | ashleyjv | |
05/6/2022 14:47 | Please don't email scammers | ashleyjv | |
05/6/2022 12:54 | Stella stop spamming all the boards | boxerdogz | |
05/6/2022 10:17 | counting down the last few days to warrants expiry and hopefully before then, the sign off on prospectus. any warrant holders wish to share feedback from webinar? | wrtmf | |
01/6/2022 15:56 | Thanks for the info, wrtmf. Looks like we are nearly there. All eyes now on what it's going to relist at. I know 0.47 was stated (or the equivalent, if there is any share dilution.) Cannabis stocks seem to be a bit unloved in the US currently. Let's hope Hellenic bucks the trend on this side of the pond. They certainly sound impressive enough. GLA. | felchandbart | |
01/6/2022 12:15 | no probs. agreed, also as boxer suggested, some pr should be green lighted shortly, but lets get past committee first | wrtmf | |
01/6/2022 11:05 | Great thanks for posting the update Let's hope they put the webinar up on you tube or similar platform for shareholders to view.Would also be of interest to potential new shareholders when we relist | gozo | |
31/5/2022 17:47 | 31 May 2022 U.K. SPAC PLC (the "Company") Letter to Shareholders and Warrant holders of U.K. SPAC PLC I am pleased to inform you that the proposed Reverse Take-Over ("RTO") of the Company by Hellenic Dynamics S.A. ("Hellenic") is now entering its final stages. While the prospectus is still subject to final approval by the FCA eligibility committee, the Directors believe that all substantive issues regarding the text of the prospectus have been addressed. Hellenic is a medical cannabis cultivation business based in a fully secure, custom designed 195,506 square meter facility in Northern Greece. Hellenic plans to grow, manufacture, process and sell medicinal cannabis flowers and related extracted oils initially into the Germany, the United Kingdom, and Greece. The Directors of Hellenic intend that it will become one of, if not the first medical cannabis cultivators to list on the Main Market of the London Stock Exchange. In advance of the Company convening the general meeting that will enable the Company and Hellenic to complete the RTO, the Company is organising a webinar on Wednesday 1 June 2022 at 14:00 (London Time) to present Hellenic Dynamics S.A. to warrant holders who participated in the U.K. SPAC placing undertaken in March 2021 ("Investor Warrants") and to discuss the conversion of these warrants. Any U.K. SPAC warrant holder interested in participating the webinar should contact Peterhouse Capital via the contacts numbers below. Peter Jay Chairman UK SPAC PLC | wrtmf | |
27/5/2022 16:35 | Hellenic Dynamics @HellenicDynami1 26 May France is legalising #medicalcannabis, with the government authorising cultivation for medicinal purposes. This decision was made following a pilot programme that was launched in 2021 to test this treatment on patients suffering severe conditions. This highlights the importance of #research and #education being a force for positive change, allowing many more people the opportunity to receive more effective treatments. | wrtmf | |
27/5/2022 07:48 | link is not working this morning - internal server error no result even if i change criteria to 1 month, which should have given 17may update. gremlins. interesting 10 days ahead, 2 of which bank holidays? long stop day today warrants expire in 10 working days -- edit 2 June Thursday Spring bank holiday 3 June Friday Platinum Jubilee bank holiday | wrtmf | |
25/5/2022 08:52 | [link removed as not functioning on repeated checks over several days] come on fca, get this over the line! | wrtmf | |
24/5/2022 11:40 | Ouch.....you've really hurt my feelings.... | muchodinero | |
24/5/2022 10:28 | muchodinero18 May '22 - 07:34 - 1110 of 1124 0 1 4 You clowns are very much mistaken about my M.O. ---------- Really? muchodinero23 May '22 - 21:39 - 939 of 942 0 1 2 Sikh...why would Skellington want to buy now a 4.5p when he could wait a few more months and buy for 1p maybe? ----------------- We all know your mo extremely well. And all are sick of it. Yet you come here expecting to have questions answered, knowing as soon as you have sold you will start a slagging campaign (hoping to buy back cheaper, or maybe just for the attention). | pierre oreilly | |
24/5/2022 10:26 | Double post. | pierre oreilly | |
24/5/2022 10:13 | So sometime in June can we assume we will get our new shares in Hellenic at the same ratio as.our UK spac holdings? | muchodinero | |
22/5/2022 21:00 | 5 days to the long stop date then 10 working days to the warrants expiry. | wrtmf | |
19/5/2022 15:59 | I assume from the deafening silence we don't have a day for the start of trading in 'Hel'..? | muchodinero |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions